MassIVE MSV000093185

Partial Public PXD046378

Proteome wide analysis of SUMO interacting proteins from Huntingtons disease R6/2 mouse striatum shows alterations in enrichment of functional synaptic proteins

Subscribe Comment Convert Spectra Add Reanalysis

Description

Huntingtons disease (HD) is a neurodegenerative disorder caused by an expanded CAG repeat mutation in the Huntingtin (HTT) gene. The mutation impacts neuronal protein homeostasis and cortical/striatal circuitry. SUMOylation, a post translational modification with broad cellular effects, directly modifies the Huntingtin protein (HTT), along with other key neuronal and synaptic proteins. Here we investigated proteome wide changes in striatal protein SUMOylation/protein SUMO interactions in the context of HD using R6/2 transgenic and non-transgenic (NT) control mice by performing SUMO protein enrichment from tissue followed by mass spectrometry. Significant changes in enrichment of known and previously unknown SUMOylated or SUMO interacting proteins were observed including those involved in presynaptic function and cytomatrix at the active zone scaffolding, cytoskeleton organization, and glutamatergic signaling. A network based approach identified altered pathways in HD tissue to include clathrin mediated endocytosis signaling, synaptogenesis signaling, synaptic long term potentiation, and SNARE signaling. Furthermore, the metabotropic glutamate receptor 7 (mGluR7), a key player in glutamatergic signaling, a core signaling pathway disrupted in HD was SUMO enriched and we show SUMO modification is enhanced by the E3 SUMO ligase Protein Inhibitor of Activated STAT1 (PIAS1). To evaluate functional measures of neuronal activity in HD cells in vitro we utilized primary neuronal cultures from R6/2 and NT mice and evaluated how modulation of SUMOylation via reduction of PIAS1 may impact specific readouts. A receptor internalization assay showed decreased mGluR7 internalization in R6/2 neurons compared to NT, and siRNA mediated knockdown of PIAS1 prevented this HD phenotype. In addition, microelectrode array analysis on primary neuron cultures indicated early timepoint hyperactivity in HD cells, while later timepoints demonstrated deficits in several measurements of neuronal activity within cortical neurons. HD phenotypes were rescued at select timepoints following knockdown of PIAS1. Taken together our results provide a mouse brain SUMO ome resource and show that significant alterations occur within the post-translational landscape and SUMO protein interactions for synaptic proteins in HD. [doi:10.25345/C5PV6BJ1D] [dataset license: CC0 1.0 Universal (CC0 1.0)]

Keywords: SUMOylation ; Huntingtons disease

Contact

Principal Investigators:
(in alphabetical order) 		Jennifer Van Eyk, Cedars Sinai Medical Center, United States
Submitting User: NivedaS5
Number of Files:
Total Size:
Spectra:
Subscribers:
 
Owner Reanalyses
Experimental Design
    Conditions:
    Biological Replicates:
    Technical Replicates:
 
Identification Results
    Proteins (Human, Remapped):
    Proteins (Reported):
    Peptides:
    Variant Peptides:
    PSMs:
 
Quantification Results
    Differential Proteins:
    Quantified Proteins:
 
Browse Dataset Files
 
FTP Download Link (click to copy):

Species

Instrument

Modifications

- Dataset Reanalyses

+ Dataset History

Click here to queue conversion of this dataset's submitted spectrum files to open formats (e.g. mzML). This process may take some time.

When complete, the converted files will be available in the "ccms_peak" subdirectory of the dataset's FTP space (accessible via the "FTP Download" link to the right).
Number of distinct conditions across all analyses (original submission and reanalyses) associated with this dataset.

Distinct condition labels are counted across all files submitted in the "Metadata" category having a "Condition" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct biological replicates across all analyses (original submission and reanalyses) associated with this dataset.

Distinct replicate labels are counted across all files submitted in the "Metadata" category having a "BioReplicate" or "Replicate" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct technical replicates across all analyses (original submission and reanalyses) associated with this dataset.

The technical replicate count is defined as the maximum number of times any one distinct combination of condition and biological replicate was analyzed across all files submitted in the "Metadata" category. In the case of fractionated experiments, only the first fraction is considered.

"N/A" means no results of this type were submitted.
Originally identified proteins that were automatically remapped by MassIVE to proteins in the SwissProt human reference database.

"N/A" means no results of this type were submitted.
Number of distinct protein accessions reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct unmodified peptide sequences reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct peptide sequences (including modified variants or peptidoforms) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Total number of peptide-spectrum matches (i.e. spectrum identifications) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins quantified across all analyses (original submission and reanalyses) associated with this dataset.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins found to be differentially abundant in at least one comparison across all analyses (original submission and reanalyses) associated with this dataset.

A protein is differentially abundant if its change in abundance across conditions is found to be statistically significant with an adjusted p-value <= 0.05 and lists no issues associated with statistical tests for differential abundance.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
This dataset may not contain all raw spectra data as originally deposited in PRIDE. It has been imported to MassIVE for reanalysis purposes, so its spectra data here may consist solely of processed peak lists suitable for reanalysis with most software.